Investors
News
Contact
Japanese
Global
About
About
Greetings
Mission Statement
Corporate Governance
Management Strategy
ONO Story
Company Overview
Business Activities
History
Main Products
Videos and Advertisements
Policies
Company Profile
Management
Business Locations
ONO Story
R＆D
Manufacturing
Marketing
Safety and Quality Assurance
Digital & IT
ONO’s 300-Year History
CLOSE
ONO Story
Videos and Advertisements
R＆D
R＆D
Our Mission in R&D / Drug Discovery Approach
In-house Drug Discovery
Open Innovation
Licensing Activities
Research Organization
Development Policy
Development Pipeline
The investigator-sponsored research support
CLOSE
Development Pipeline
Global Business
Sustainability
Sustainability
Top Message
ONO's Approach to Sustainability
Environment
Society
Governance
Stakeholder Engagement
Social Contribution Activities
Policies
GRI Standards Content Index
Sustainability Report
ESG Data
External Evaluation
Independent Practitioner's Assurance
Corporate Governance
Compliance
Risk Management
Responsible Promotion Activities
Innovative Pharmaceutical Products
Efforts Made for Improving Access to Healthcare
Respect for Human Rights
Expansion of Human Capital (Talent Development and Employment)
Expansion of Human Capital (Fostering an Organizational Climate and Culture that realizes high employee engagement)
Expansion of Human Capital (Health Management)
Sustainable Procurement
Commitment to Conservation of the Global Environment
Information Disclosure Based on the TCFD Recommendation
Realization of a Decarbonized Society
Realization of a Water Recycling Society
Realization of a Resource Recycling Society
Information Disclosure Based on the TNFD Recommendations
Biodiversity
EHS Management
Environmental Accounting
Stakeholder Engagement
Dialogue with Shareholders and Investors
Cooperation with Governments
Social Contribution Activities
Efforts for the Advancement of Medicine and Pharmacy
Efforts for Supporting Health of Patients and Their Families
Efforts Toward Environmental Conservation for the Health of Everyone
Efforts Toward an Education for the Children’s Health
Efforts for Improvement of the Medical Ecosystem
CLOSE
ECO VISION 2050
Improving Access to Healthcare
icon_search_white
icon_close_w
Search
About
About
Top
Greetings
Mission Statement
Corporate Governance
Management Strategy
ONO Story
Company Overview
History
Main Products
Videos and Advertisements
Policies
Business Activities
R&D
Manufacturing
Marketing
Safety and Quality Assurance
Digital & IT
R＆D
R＆D
Top
Our Mission in R&D / Drug Discovery Approach
In-house Drug Discovery
Open Innovation
Licensing Activities
Research Organization
Development Policy
Development Pipeline
The investigator-sponsored research support
Global Business
Global Business
Top
Sustainability
Sustainability
Top
Top Message
ONO's Approach to Sustainability
Environment
Society
Governance
Stakeholder Engagement
Social Contribution Activities
Policies
GRI Standards Content Index
Sustainability Report
ESG Data
External Evaluation
Independent Practitioner's Assurance
icon_search_g
Search
Governance :
Governance
Corporate Governance
Corporate Governance Structure
Corporate Governance Code
Corporate Governance Report
Internal Control System
Compliance
ONO Pharmaceutical’s Compliance System
Initiatives to Strengthen Compliance System
Immediate response to serious compliance violations in FY2020
Risk Management
Risk Management
Business Continuity Plan (BCP)
Major Risks
Information Security Management
Responsible Promotion Activities
Basic approach
Pursuit of fair promotion activities
Management system for promotion activities
Review system for promotional materials
Training for thorough implementation of fair promotion activities
Training for promoting proper use of pharmaceuticals and collecting safety information
ONO PHARMACEUTICAL CO.,LTD., ONO PHARMACEUTICAL CO.,LTD., system
